Efficacy of a clinical pathway for patients with thyroid cancer

Head Neck. 2018 Sep;40(9):1909-1916. doi: 10.1002/hed.25175. Epub 2018 Apr 10.

Abstract

Background: Clinical pathways have been proposed as a way to improve organizational efficiency and maximize patient outcomes. However, little is known as to whether a clinical pathway is effective for thyroid cancer.

Methods: The study subjects included 216 patients who were managed after clinical pathway implementation and 145 control patients. Length of stay, cost per patient, and nurses' satisfaction were compared in the 2 groups.

Results: Mean length of stay was 0.8 days shorter in the clinical pathway group than in the control group (2.9 vs 3.7 days; P = .023). Cost per patient was also lower in the clinical pathway than in the control group (USD $3953.00 vs USD $4636.00; P < .001). Nurses' overall satisfaction scores improved from 71.6% before to 82.5% after implementation of the clinical pathway and their job characteristics scores increased from 61.1% to 75.0%.

Conclusion: Implementation of a clinical pathway for thyroid cancer can improve nurses' satisfaction with reduction of hospital stay and costs.

Keywords: clinical pathway; efficacy; nurse satisfaction; standardization; thyroid cancer.

MeSH terms

  • Adult
  • Attitude of Health Personnel
  • Controlled Before-After Studies
  • Critical Pathways*
  • Female
  • Health Care Costs
  • Humans
  • Job Satisfaction
  • Length of Stay
  • Male
  • Middle Aged
  • Nursing Staff, Hospital
  • Thyroid Neoplasms / therapy*
  • Thyroidectomy